05 Approved biologics for SLE: which to try first and in which patients? – The case for belimumab
Main Author: | Ronald van Vollenhoven |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-09-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
06 Approved biologics for SLE: which to try first and in which patients? – The case for anifrolumab
by: Eric Morand
Published: (2023-09-01) -
I17 Choosing wisely: which biological should we use in which patient?
by: Ronald van Vollenhoven
Published: (2024-03-01) -
22 New and approved therapies for SLE: Anifrolumab
by: Ronald van Vollenhoven
Published: (2022-04-01) -
Editorial: Mechanisms by Which SLE-Associated Genetic Variants Contribute to SLE Pathogenesis
by: José C. Crispín, et al.
Published: (2019-12-01) -
25 Disease modification in SLE: an introduction
by: Ronald van Vollenhoven
Published: (2023-09-01)